TransMedics Group, Inc.
TMDX Healthcare Medical Devices
TransMedics Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $605.5 million, up 37.1% from fiscal 2024. In the quarter to June 2026, revenue grew 20.7%, EPS fell 59.2%, free cash flow fell 87.6% and total debt rose 68.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow TMDX
TransMedics Group, Inc. (TMDX) P/E ratio
As of 16 October 2026, TransMedics Group, Inc. (TMDX) trades at a P/E ratio of 16.0×. Over the past ten years it has ranged from 0.0× (June 2024) to 2,201× (August 2024); the current reading is higher than 71% of that period. That is below the Medical Devices industry median of 23.2× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 21.8× | (62.59%) |
| FY2024 | 58.3× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 15.0× | (23.97%) |
| Mar 2026 | 19.8× | (9.35%) |
| Dec 2025 | 21.8× | (47.54%) |
| Sep 2025 | 41.6× | (34.26%) |
| 30 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BFLY Butterfly Network, Inc. compare | n/m |
| ESTA Establishment Labs Holdings Inc. compare | n/m |
| NEOG Neogen Corporation compare | n/m |
| IRTC iRhythm Holdings, Inc. compare | n/m |
| AXGN AxoGen, Inc. compare | n/m |
| ATEC Alphatec Holdings, Inc. compare | n/m |
| INSP Inspire Medical Systems, Inc. compare | 14.8× |
| TMDX TransMedics Group, Inc. | 16.0× |
| UFPT UFP Technologies, Inc. compare | 31.2× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)